Astrazeneca Pharma India Receives Permission To Import Durvalumab For Additional Indication
Reuters
02-28
Feb 28 (Reuters) - Astrazeneca Pharma India Ltd :: *RECEIVES PERMISSION TO IMPORT DURVALUMAB FOR ADDITIONAL INDICATION *GETS PERMISSION FROM CENTRAL DRUGS STANDARD CONTROL ORGANISATION, INDIA